Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving nucleic acid
Reexamination Certificate
2011-01-18
2011-01-18
Woolwine, Samuel (Department: 1637)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving nucleic acid
C435S007100, C435S091200, C435S960000, C536S024310, C536S024330
Reexamination Certificate
active
07871769
ABSTRACT:
The present invention provides sets of genes the expression of which is important in the prognosis of cancer. In particular, the invention provides gene expression information useful for predicting whether cancer patients are likely to have a beneficial treatment response to chemotherapy FHIT; MTA1; ErbB4; FUS; BBC3; IGF1R; CD9; TP53BP1; MUC1; IGFBP5; rhoC; RALBP1; STAT3; ERK1; SGCB; DHPS; MGMT; CRIP2; ErbB3; RAP1GDS1; CCND1; PRKCD; Hepsin; AK055699; ZNF38; SEMA3F; COL1A1; BAG1; AKT1; COL1A2; Wnt.5a; PTPD1; RAB6C; GSTM1, BCL2, ESR1; or the corresponding expression product, is determined, said report includes a prediction that said subject has a decreased likelihood of response to chemotherapy.
REFERENCES:
patent: 4699877 (1987-10-01), Cline et al.
patent: 4968603 (1990-11-01), Slamon et al.
patent: 5015568 (1991-05-01), Tsujimoto et al.
patent: 5202429 (1993-04-01), Tsujimoto et al.
patent: 5459251 (1995-10-01), Tsujimoto et al.
patent: RE35491 (1997-04-01), Cline et al.
patent: 5670325 (1997-09-01), Lapidus et al.
patent: 5741650 (1998-04-01), Lapidus et al.
patent: 5830665 (1998-11-01), Shuber et al.
patent: 5830753 (1998-11-01), Coulie et al.
patent: 5858678 (1999-01-01), Chinnadurai
patent: 5861278 (1999-01-01), Wong et al.
patent: 5928870 (1999-07-01), Lapidus et al.
patent: 5952178 (1999-09-01), Lapidus et al.
patent: 5952179 (1999-09-01), Chinnadurai
patent: 5962312 (1999-10-01), Plowman et al.
patent: 5985553 (1999-11-01), King et al.
patent: 6020137 (2000-02-01), Lapidus et al.
patent: 6100029 (2000-08-01), Lapidus et al.
patent: 6143529 (2000-11-01), Lapidus et al.
patent: 6146828 (2000-11-01), Lapidus et al.
patent: 6171798 (2001-01-01), Levine et al.
patent: 6203993 (2001-03-01), Shuber et al.
patent: 6207401 (2001-03-01), Plowman et al.
patent: 6207452 (2001-03-01), Govindaswamy
patent: 6214558 (2001-04-01), Shuber et al.
patent: 6245523 (2001-06-01), Altieri
patent: 6248535 (2001-06-01), Danenberg et al.
patent: 6271002 (2001-08-01), Linsley et al.
patent: 6322986 (2001-11-01), Ross
patent: 6414134 (2002-07-01), Reed
patent: 6582919 (2003-06-01), Danenberg
patent: 6602670 (2003-08-01), Danenberg
patent: 6618679 (2003-09-01), Loehrlein et al.
patent: 6620606 (2003-09-01), Bandman et al.
patent: 6696558 (2004-02-01), Reed et al.
patent: 6716575 (2004-04-01), Plowman et al.
patent: 6750013 (2004-06-01), Gish et al.
patent: 6800737 (2004-10-01), Altieri
patent: 6943150 (2005-09-01), Altieri
patent: 7081340 (2006-07-01), Baker et al.
patent: 7171311 (2007-01-01), Dai et al.
patent: 7526387 (2009-04-01), Baker et al.
patent: 7569345 (2009-08-01), Cobleigh et al.
patent: 7622251 (2009-11-01), Baker et al.
patent: 2001/0051344 (2001-12-01), Shalon et al.
patent: 2002/0004491 (2002-01-01), Xu et al.
patent: 2002/0009736 (2002-01-01), Wang
patent: 2002/0039764 (2002-04-01), Rosen
patent: 2002/0160395 (2002-10-01), Altieri et al.
patent: 2003/0073112 (2003-04-01), Zhang et al.
patent: 2003/0104499 (2003-06-01), Pressman et al.
patent: 2003/0165952 (2003-09-01), Linnarsson et al.
patent: 2003/0180791 (2003-09-01), Chinnadurai
patent: 2003/0198970 (2003-10-01), Roberts
patent: 2003/0198972 (2003-10-01), Erlander et al.
patent: 2003/0219771 (2003-11-01), Bevilacqua et al.
patent: 2003/0229455 (2003-12-01), Bevilacqua et al.
patent: 2004/0009489 (2004-01-01), Golub et al.
patent: 2004/0126775 (2004-07-01), Altieri et al.
patent: 2004/0133352 (2004-07-01), Bevilacqua et al.
patent: 2005/0266420 (2005-12-01), Pusztai et al.
patent: 2006/0166230 (2006-07-01), Baker et al.
patent: 2007/0059737 (2007-03-01), Baker et al.
patent: 2007/0065845 (2007-03-01), Baker et al.
patent: 2007/0065846 (2007-03-01), Baker et al.
patent: 2007/0141587 (2007-06-01), Baker et al.
patent: 2007/0141588 (2007-06-01), Baker et al.
patent: 2007/0141589 (2007-06-01), Baker et al.
patent: 2008/0182255 (2008-07-01), Baker et al.
patent: 2009/0125247 (2009-05-01), Baker et al.
patent: 2009/0280490 (2009-11-01), Baker et al.
patent: 0 108 564 (1988-05-01), None
patent: 1 365 034 (2003-11-01), None
patent: WO 99/02714 (1999-01-01), None
patent: WO 00/50595 (2000-08-01), None
patent: WO 00/55173 (2000-09-01), None
patent: WO 00/70085 (2000-11-01), None
patent: WO 01/25250 (2001-04-01), None
patent: WO 01/40466 (2001-06-01), None
patent: WO 01/55320 (2001-08-01), None
patent: WO 01/70979 (2001-09-01), None
patent: WO 02/00677 (2002-01-01), None
patent: WO 02/06526 (2002-01-01), None
patent: WO 02/08260 (2002-01-01), None
patent: WO 02/08261 (2002-01-01), None
patent: WO 02/08282 (2002-01-01), None
patent: WO 02/08765 (2002-01-01), None
patent: WO 02/10436 (2002-02-01), None
patent: WO 02/46467 (2002-06-01), None
patent: WO 02/017852 (2002-07-01), None
patent: WO 02/055988 (2002-07-01), None
patent: WO 02/059377 (2002-08-01), None
patent: WO 02/068579 (2002-09-01), None
patent: WO 02/103320 (2002-12-01), None
patent: WO 03/011897 (2003-02-01), None
patent: WO03/078662 (2003-09-01), None
patent: WO 03/083096 (2003-10-01), None
patent: WO2004/065583 (2004-08-01), None
patent: WO2004/074518 (2004-09-01), None
patent: WO2004/111603 (2004-12-01), None
patent: WO2005/008213 (2005-01-01), None
patent: WO2005/039382 (2005-05-01), None
patent: WO2006/052731 (2006-05-01), None
patent: WO2006/052862 (2006-05-01), None
patent: WO2007/123772 (2007-11-01), None
patent: WO2009/026128 (2009-02-01), None
patent: WO2009/140304 (2009-11-01), None
Kroese et al (Genetics in Medicine, vol. 6, pp. 475-480, 2004).
Lucentini (The Scientist, vol. 18, p. 20, 2004).
Murphy et al. (Pathology, 2005, vol. 37(4), pp. 271-277).
Korfee et al. (Current Pharmacogenomics, 2005. vol. 3, pp. 201-216).
GenBank GI:10190747 [online] Sep. 28, 2008 [retrieved on May 1, 2009] retrieved from http://www.ncbi.nlm.nih.gov
uccore/10190747 (6 pages).
Cheng et al. SCUBE2 Suppresses Breast Tumor Cell Proliferation and Confers a Favorable Prognosis in Invasive Breast Cancer. Cancer Res. 69(8):3634-3641, Apr. 15, 2009.
Brabender, Jan, et al.;Epidermal Growth Factor Receptor and HER2-neu mRNA Expression in Non-Small Cell Lung Cancer Is Correlated with Survival, Clinical Cancer Research; vol. 7, Jul. 2001; pp. 1850-1855.
Ding, Chunming, et al.;A high-throughput gene expression analysis technique using competitive PCR and matrix-assisted laser desorption ionization time-of-flight MS, PNAS, vol. 100:6; Mar. 18, 2003; pp. 3059-3064.
Cambridge Healthtech Institute Conference Agenda; “Enabling Molecular Profiling With Cellular Resolution: Microgenomics Using Homogeneous Cell Samples”; Dec. 2002; 5 pgs.
Yang, Li, et al.;BADGE,BeadsArray for theDetection ofGeneExpression, a High-Throughput Diagnostic Bioassay; Genome Research; vol. 11; 2001; pp. 1888-1898.
Affymetrix Inc.: “Affymetrix GeneChip Human Genome U95 Version 2 Set HG-U95A,”GEO, XX, XX, 1-243 (2002).
Bertucci, F. et al.: “Gene Expression Profiles of Poor-Prognosis Primary Breast Cancer Correlate with Survival” Human Molecular Genetics, Oxford University Press, Surrey, GB, vol. 11, No. 8. Apr. 15, 2002 (pp. 863-872).
Johnson, Sandra A.S. et al.: “Increased Expression of TATA-Binding Protein, the Central Transcription Factor, Can Contribute to Oncogenesis”, Molecular and Cellular Biology, vol. 23, No. 9, May 2003 (pp. 8043-3051).
Muss, H. B. et al.: “C-ERBB-2 Expression and Response to Adjuvant Therapy in Women with Node-Positive Early Breast Cancer” New England Journal of Medicine, Massachusetts Medical Society, Boston, MA, US, vol. 330, No. 18, May 5, 1994 (pp. 1260-1266).
Ring, A. E. et al.: “Predictors of Response to Systemic Therapy in Breast Cancer” Forum, Genova, IT, vol. 12, No. 1, 2002, (pp. 19-32).
Sorlie, T. et al.: “Gene Expression Patterns of Breast Carcinomas Distinguish Tumor Subclasses with Clinical Implications” Proceeding of the National Academy of Sciences of USA, National Academy of Science, Washington, DC, US, vol. 98, No. 19. Sep. 11, 2001 (pp. 10869-10874).
Sotiriou, C. et al.: “Gene Expression Profiles Derived from Fine Needle Aspiration Correlate with Response to Systemic Chemotherapy in Br
Baker Joffre B.
Gianni Luca
Shak Steven
Bozicevic Field & Francis LLP
Francis Carol L.
Genomic Health, Inc.
Instituto Nazionale Tumori
Keddie James S.
LandOfFree
Gene expression markers for predicting response to chemotherapy does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Gene expression markers for predicting response to chemotherapy, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Gene expression markers for predicting response to chemotherapy will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2696681